Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone - effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein
- 1 June 1983
- Vol. 5 (1), 1-8
- https://doi.org/10.1016/0378-5122(83)90015-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effects on sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyl-oestradiol and norethisteroneMaturitas, 1981
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens*Journal of Clinical Endocrinology & Metabolism, 1979
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- Conjugated equine oestrogens and blood clotting: a follow-up report.BMJ, 1977
- A radioimmunoassay for “the pregnancy zone protein”Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Surgically Confirmed Gallbladder Disease, Venous Thromboembolism, and Breast Tumors in Relation to Postmenopausal Estrogen TherapyNew England Journal of Medicine, 1974
- Radioimmunological Methods for the Estimation of Oestrone, Oestradiol 17β and Oestriol in Pregnancy PlasmaPublished by Wiley ,1974
- The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research GroupPublished by American Medical Association (AMA) ,1973
- A new method for the determination of the binding capacity of testosterone-estradiol-binding-globulin in human plasmaJournal of Steroid Biochemistry, 1973
- Hypertension, Oral Contraceptive Agents, and Conjugated EstrogensAnnals of Internal Medicine, 1971